A Phase 2, Double-blind, Randomized, Placebo-controlled Milticenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus
Clinical Trial Grant
Administered By
Medicine, Rheumatology and Immunology
Awarded By
Emory University
Start Date
May 1, 2019
End Date
April 30, 2022
Administered By
Medicine, Rheumatology and Immunology
Awarded By
Emory University
Start Date
May 1, 2019
End Date
April 30, 2022